ジフテリアトキソイド
WordNet
- acute contagious infection caused by the bacterium Corynebacterium diphtheriae; marked by the formation of a false membrane in the throat and other air passages causing difficulty in breathing
PrepTutorEJDIC
- ジフテリア(呼吸困難を起こすのどの病気)
Wikipedia preview
出典(authority):フリー百科事典『ウィキペディア(Wikipedia)』「2015/10/13 12:54:47」(JST)
[Wiki en表示]
Diphtheria vaccine
Vaccine description |
Target disease |
Corynebacterium diphtheriae |
Type |
Toxoid |
Clinical data |
MedlinePlus |
a607027 |
Routes of
administration |
Intramuscular injection |
Identifiers |
CAS Registry Number |
Y |
ATC code |
J07AF01 |
N (what is this?) (verify) |
Diphtheria vaccine is a vaccine used against Corynebacterium diphtheriae, the agent that causes diphtheria.[1] It use has resulted in a more than 90% decrease in number of cases globally between 1980 and 2000.[2] Three initial doses are recommended after which it is about 95% effective.[2] It is effective for about 10 years at which time a booster dose is needed.[2] Immunization may start at six weeks of age with further doses given every four weeks.[2]
The diphtheria vaccine is very safe.[2] Significant side effects are rare.[2] Pain may occur at the injection site.[2] A bump may form at the site of injection that lasts a few weeks.[3] The vaccine is safe in both pregnancy and among those who have a poor immune function.[3]
Several combination vaccines are used to prevent diphtheria.[4] This includes with tetanus toxoid (known as dT or DT vaccine) and with tetanus and pertussis vaccine known as DPT vaccine.[2] The World Health Organization has recommended it use since 1974.[2] About 84% of the world population is vaccinated.[5] It is given as a intramuscular injection.[2] The vaccine needs to be kept cold but not frozen.[3]
It is on the World Health Organization's List of Essential Medicines, the most important medication needed in a basic health system.[6]
References
- ^ "MedlinePlus Medical Encyclopedia: Diphtheria immunization (vaccine)". Retrieved 2009-03-07. [dead link]
- ^ a b c d e f g h i j "Diphtheria vaccine" (PDF). Wkly Epidemiol Rec 81 (3): 24–32. Jan 20, 2006. PMID 16671240.
- ^ a b c Atkinson, William (May 2012). Diphtheria Epidemiology and Prevention of Vaccine-Preventable Diseases (12 ed.). Public Health Foundation. pp. 215–230. ISBN 9780983263135.
- ^ "Diphtheria Vaccination". Department of Health and Human Services. Retrieved 8 November 2011.
- ^ "Diphtheria". who.int. 3 September 2014. Retrieved 27 March 2015.
- ^ "WHO Model List of EssentialMedicines" (PDF). World Health Organization. October 2013. Retrieved 22 April 2014.
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
English Journal
- Evolution, epidemiology and diversity of Corynebacterium diphtheriae: New perspectives on an old foe.
- Sangal V1, Hoskisson PA2.
- Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.Infect Genet Evol.2016 Sep;43:364-70. doi: 10.1016/j.meegid.2016.06.024. Epub 2016 Jun 9.
- Diphtheria is a debilitating disease caused by toxigenic Corynebacterium diphtheriae strains and has been effectively controlled by the toxoid vaccine, yet several recent outbreaks have been reported across the globe. Moreover, non-toxigenic C. diphtheriae strains are emerging as a major global heal
- PMID 27291708
- State of inequality in diphtheria-tetanus-pertussis immunisation coverage in low-income and middle-income countries: a multicountry study of household health surveys.
- Hosseinpoor AR1, Bergen N2, Schlotheuber A3, Gacic-Dobo M4, Hansen PM5, Senouci K4, Boerma T3, Barros AJ6.
- The Lancet. Global health.Lancet Glob Health.2016 Sep;4(9):e617-26. doi: 10.1016/S2214-109X(16)30141-3. Epub 2016 Aug 3.
- BACKGROUND: Immunisation programmes have made substantial contributions to lowering the burden of disease in children, but there is a growing need to ensure that programmes are equity-oriented. We aimed to provide a detailed update about the state of between-country inequality and within-country eco
- PMID 27497954
- Incompatibility of lyophilized inactivated polio vaccine with liquid pentavalent whole-cell-pertussis-containing vaccine.
- Kraan H1, Ten Have R2, van der Maas L1, Kersten G3, Amorij JP4.
- Vaccine.Vaccine.2016 Aug 31;34(38):4572-8. doi: 10.1016/j.vaccine.2016.07.030. Epub 2016 Jul 26.
- A hexavalent vaccine containing diphtheria toxoid, tetanus toxoid, whole cell pertussis, Haemophilius influenza type B, hepatitis B and inactivated polio vaccine (IPV) may: (i) increase the efficiency of vaccination campaigns, (ii) reduce the number of injections thereby reducing needlestick injurie
- PMID 27470209
Japanese Journal
- Immunity to Diphtheria and Tetanus in Army Personnel and Adult Civilians in Mashhad, Iran
- Knowledge, attitudes, beliefs and practices of construction workers towards tetanus vaccine in Northern Italy
- Immunity to diphtheria and tetanus in Army personnel and adult civilians in Mashhad, Iran
Related Links
- Diphtheria Greek diphthera (leather hide) Recognized by Hippocrates in 5th century BCE Epidemics described in 6th century C. diphtheriae described by Klebs in 1883 Toxoid developed in 1920s Corynebacterium ...
- Physician reviewed Tetanus-Diphtheria Toxoids, Adult patient information - includes Tetanus-Diphtheria Toxoids, Adult description, dosage and directions. ... What other drugs will affect tetanus and diphtheria toxoids vaccine? Before ...
Related Pictures
★リンクテーブル★
[★]
- 英
- diphtheria toxoid
- 同
- ジフテリアワクチン、沈降ジフテリアトキソイド、成人用沈降ジフテリアトキソイド
- 関
- ジフテリア、抗毒素製剤、トキソイド、予防接種
[★]
- 同
- Tdap, BOOSTRIX, ADACEL